Allylamine

Global Antifungal Agents Market Report 2022: Rising Incidences of Fungal Diseases Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Jeudi, octobre 20, 2022
Health, Other Health, MSD, Skin infection, CDC, Pandion, Laboratory, Aspergillosis, Therapy, Growth, Abbott Laboratories, Antifungal, Pfizer, CAGR, Bayer, Patient, Fungus, Mycosis, Surgeon, Watchlist, Powder, Azole, World Health Organization, Infection, Partnership, WHO, Candidiasis, Center, World, Acquisition, Dermatophytosis, Africa Centres for Disease Control and Prevention, Joint Medical Service (Germany), Pathogenic fungus, Tinea versicolor, Bacteria, Death, Tablet, Canker, Polyene, Vaccine, Pharmaceutical industry, Merck, Echinocandin, Allylamine

The global antifungal agents market is anticipated to grow at a significant CAGR of nearly 3.5% during the forecast period.

Key Points: 
  • The global antifungal agents market is anticipated to grow at a significant CAGR of nearly 3.5% during the forecast period.
  • Antifungal agents prevent and destroy the growth of fungi that are responsible for several diseases such as aspergillosis, ringworm, and skin infection, among others.
  • Antifungal agents are a class of drugs that are used to detect and eliminate fungal infections from the body with minimal side effects.
  • Another major factor contributing to the growth of the market is the rising incidences of fungal diseases.

Global Anti-Fungal Drugs (Azoles, Echinocandins, Polyenes, Allylamines, Others) Markets, 2016-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Vendredi, octobre 8, 2021
Health, Pharmaceutical, Well, Dermatophytosis, Mycosis, Fungal pneumonia, Administration, Route of administration, Polyene, USD, Mucormycosis, Global, CAGR, Ketoconazole, Finger, Investment, Candidiasis, Prevalence, Allylamine, Miconazole, Awareness, Onychomycosis, Market share, Patient, Research, Econazole, Pharmaceutical industry, Fine chemical, Retail

The Global Anti-fungal Drugs Market is expected to reach USD 28484.69 million by 2026, growing at CAGR of 10.39%.

Key Points: 
  • The Global Anti-fungal Drugs Market is expected to reach USD 28484.69 million by 2026, growing at CAGR of 10.39%.
  • An increase in the use of anti-fungal drugs coupled with the rising number of anti-fungal drugs available over-the-counter is expected to boost the market demand.
  • With the surge in popularity of over-the-counter drugs such as ketoconazole, miconazole, econazole, amorolfine, several patients are preferring over-the-counter drugs.
  • The Global Anti-fungal Drugs Market is segmented into drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company.

India $1.56 Bn Anti-Fungal Drugs Markets, Competition Forecast & Opportunities, FY2027 - ResearchAndMarkets.com

Retrieved on: 
Jeudi, août 12, 2021
Health, Pharmaceutical, Research, Administration, Dermatophytosis, Mycosis, Adoption, Route of administration, Health, Coronavirus, Polyene, Awareness, Investment, Social media, CAGR, Growth, Market share, Mucormycosis, Prevalence, Foot, Patient, Candidiasis, Allylamine, Health insurance, Pharmaceutical industry, Retail

Anti-fungal drugs inhibit the growth of fungus on the host cell and eliminate the presence of fungal infection.

Key Points: 
  • Anti-fungal drugs inhibit the growth of fungus on the host cell and eliminate the presence of fungal infection.
  • Increasing investments to continue research and development activities for development of anti-fungal drugs is expected to accelerate the market growth for the forecast period.
  • Rise in awareness towards keeping a healthy body and adoption of healthy lifestyle is fostering the anti-fungal drugs market growth.
  • Also, the use of anti-fungal drugs in treatment of coronavirus is expected to propel the growth of the anti-fungal drugs market.